Cancer Research Technology
Log in Register
Menu

Anti-CD20 [B20] monoclonal Antibody

Invented at Netherlands Cancer Institute

Info

Catalogue Number 154781
Applications ELISA FACS IP
Antigen/Gene or Protein Targets CD20
Synonyms B-lymphocyte antigen CD20
Reactivity Human
Relevance CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity.
Host Mouse
Immunogen Daudi cells (Burkitt lymphoma)
Subclass IgG1
Molecular Weight (kDa) 35
Myeloma Used Sp2/0-Ag14
Recommended Growing Conditions IMDM + 1% ZAP, 37 ⁰C 5% CO2
Strain Balb/c
Notes Fusion partners: SP2/0 x spleen cells origin BALB/C.
Research Area Cell Type or Organelle Marker, Immunology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Hooijberg et al. 1996. Hybridoma. 15(1):23-31. PMID: 9064283.


Add a reference

References: 1 entry

Hooijberg et al. 1996. Hybridoma. 15(1):23-31. PMID: 9064283.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor